Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.
Title | Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel. |
Publication Type | Journal Article |
Year of Publication | 2012 |
Authors | Korantzis, I., Kalogeras K. T., Papaxoinis G., Kotoula V., Koutras A., Soupos N., Papakostas P., Dionysopoulos D., Samantas E., Christodoulou C., Linardou H., Pectasides D., & Fountzilas G. |
Journal | Anticancer Res |
Volume | 32 |
Issue | 10 |
Pagination | 4569-80 |
Date Published | 2012 Oct |
ISSN | 1791-7530 |
Keywords | Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antineoplastic Agents, Biomarkers, Tumor, Breast Neoplasms, Disease-Free Survival, Docetaxel, Female, Gene Expression Regulation, Neoplastic, Humans, Interleukin-8, Middle Aged, Neoplasms, Cystic, Mucinous, and Serous, Neovascularization, Pathologic, Receptor, ErbB-2, Severity of Illness Index, Taxoids, Transforming Growth Factor beta1 |
Abstract | BACKGROUND: Metronomic chemotherapy targets the inhibition of tumor growth primarily through antiangiogenic mechanisms. The aim of the present study was to investigate the antiangiogenic properties of weekly metronomic docetaxel administration in patients with metastatic breast cancer. |
Alternate Journal | Anticancer Res |
PubMed ID | 23060588 |